Pharmaceutical Executive
February 12, 2018
Features
38
2
Whether the pharma industry is navigating calm or choppy waters, it should be smarter and more assertive in telling its story to its stakeholders-most importantly, patients and the wider public.
February 12, 2018
Features
38
2
Pharm Exec chronicles the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader-a C-suite must in reviving the industry’s beleaguered reputation.
February 12, 2018
Features
38
2
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
February 11, 2018
Features
38
2
Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
February 06, 2018
Columns
38
2
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
February 06, 2018
Columns
38
2
Assembling a few rare slivers of pharma positivity on UK’s future.
February 06, 2018
From the Editor
38
2
Drawing parallels from the world of football coaching in evaluating and grooming future C-suite pharma leaders-call it the quest to see "what right looks like?"
February 02, 2018
Features
38
2
2017 was a year of swings and momentum for the pharma and biotech markets. Is more stable footing ahead?
February 01, 2018
Special Sponsored Section
38
2
In its ambition to further strengthen the nation’s relationship with the global industry, Brazil holds a valuable, eye-catching asset: the dynamism of its huge pharmaceutical market, the sixth-largest in the world.
February 01, 2018
Issue PDF
38
2
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.